0
2022
Implantable Cardiac Monitors Market

Implantable Cardiac Monitors Market

by Indication (Cardiac Arrrythmias, Atrial Fribrillation, Epilepsy And Unexplained Falls), by End User (Hospitals And Clinics, Home Settings, Ambulatory Surgical Centers (Ascs)): Global Opportunity Analysis and Industry Forecast, 2020-2030

✷  Report Code: A04166
Mar 2022 | Pages: 115
Tables: 81
Charts: 47
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Implantable Cardiac Monitors Market Statistics - 2030

The global implantable cardiac monitors market was valued at $500.02 million in 2020, and is projected to reach $974.42 million by 2030, growing at a CAGR of 7.2% from 2021 to 2030. Implantable cardiac monitor (ICM) is a small electrophysiology (EP) device that is used for long-term monitoring of heart electrical activity of a patient to detect arrhythmias. The technology can eliminate the need for a bulky external Holter monitor that requires wire attached to the patient. ICMs can be inserted under the skin during the office visit and record cardiac data continuously for up to 4.5 years. It allows doctor to remotely monitor the heartbeat while performing daily activities. Some of the examples of the ICMs primarily include reconstructive joint replacements, cardiac pacemakers, defibrillators, stents, valves, electrical leads/batteries, tissue-engineered constructs, and drug delivery systems. In addition, it is called as cardiac event recorder that is placed under the chest skin by performing a minor surgery. Implantable loop recorder can capture information that a standard electrocardiogram (ECG) or Holter monitor may miss, particularly arrhythmias that are brief or infrequent. Implantable loop recorder monitors heartbeat for longer time, hence, is expected to capture condition of heart if the patient faints. Information from an implantable loop recorder help the doctor confirm a diagnosis and develop treatment plan.

The COVID-19 pandemic restrained the industry growth significantly, owing to decline in demand for ICMs. All routine implantable surgeries were suspended in countries during the pandemic as medical professionals, auxiliaries, as well as patients undergoing implant procedures have high risk of cross-infection in the COVID-19 pandemic. Thus, the outbreak of COVID-19 has negatively impacted the implantable cardiac monitors market size.

The growth of the implantable cardiac monitors market share is driven by longevity offered by this device, implantable nature of this monitor which does not require patient to be admitted to hospital, and patient can be monitored while performing his or her daily activities. Moreover, increase in incidence of patients suffering from atrial fibrillation, rise in prevalence of myocardial infraction, and surge in unhealthy lifestyle contribute toward the implantable cardiac monitors market trends. However, availability of alternative mode of treatment and inflated cost of this device are expected to hinder the implantable cardiac monitors market growth. Conversely, increase in awareness among patients about these devices and treatment options for management of cardiac disorders is expected to provide lucrative opportunities for the growth of implantable cardiac monitors industry.

The global implantable cardiac monitors market size is segmented on the basis of indication, end user, and region. Depending on indication, it is categorized into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. According to end user, it is classified into hospitals and clinics, home settings, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Implantable Cardiac Monitors Market

Depending on the indication, cardiac arrhythmias segment dominated the implantable cardiac monitors market size in 2020 and is anticipated to remain dominant during the forecast period. Cardiac arrhythmias accounted for a significant share, due to the growth in incidences of cardiac arrhythmias and high mortality rate for these cardiac arrhythmias. For instance, according to WHO, an estimated 17.7 million individuals die each year due to cardiac arrhythmias, which is projected to be 31% of all deaths globally. This increase in cardiac arrhythmias globally is expected to create demand for implantable cardiac monitors, which would further create lucrative opportunities for key market players globally.

Implantable Cardiac Monitors Market

According to end user, hospitals and clinics dominated the market in 2020, and is anticipated to remain dominant during the forecast period, due to devices cannot be operated outside the hospitals and require trained professionals for carrying out the surgery. Also, high usage of cardiac monitoring devices in hospitals and clinics for acute care, non-acute care, and non-treatment purposes drives the hospital segment in forecast period.

The global implantable cardiac monitors market based on region is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominated the market in 2020 and is expected to remain dominant throughout the implantable cardiac monitors market forecast period. This is attributed to increase in incidence of chronic heart diseases, surge in demand for implantable cardiac devices, rise in availability of advanced healthcare facilities with trained medical professionals, surge in number of R&D activities along with presence of key players, and growth in government investments in healthcare system. The U.S. implantable cardiac monitor market accounted for the majority share of the North American market in 2020, owing to unhealthy lifestyles of the people leading to cardiovascular disorders, and growth in aging population, which is highly susceptible to such abnormalities.

However, Asia-Pacific is expected to experience highest growth rate during the forecast period. Moreover, Japan and China are expected to grow at highest CAGR in Asia-Pacific implantable cardiac monitors market, due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of implants.

The report provides a comprehensive analysis of the key players operating in the global implantable cardiac monitors market such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. The other players of the global implantable cardiac monitors market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., ReliantHeart Inc., Abiomed, Inc., Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.

Implantable Cardiac Monitors Market

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the implantable cardiac monitors market analysis from 2020 to 2030 to identify the prevailing Implantable Cardiac Monitors Market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the implantable cardiac monitors market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global implantable cardiac monitors market trends, key players, market segments, application areas, and market growth strategies.

Implantable Cardiac Monitors Market Report Highlights

Aspects Details
By Indication
  • Cardiac Arrrythmias
  • Atrial Fribrillation
  • Epilepsy And Unexplained Falls
By End User
  • Ambulatory Surgical Centers (Ascs)
  • Hospitals And Clinics
  • Home Settings
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Africa, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players ABBOTT LABORATORIES, EDWARDS LIFE SCIENCE CORPORATION, Boston Scientific Corporation
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Cardiac Arrrythmias

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Atrial Fribrillation

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Epilepsy And Unexplained Falls

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

  • CHAPTER 5: IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals And Clinics

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Home Settings

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Ambulatory Surgical Centers (Ascs)

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Indication

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Indication
          • 6.2.4.1.2 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Indication
          • 6.2.4.2.2 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Indication
          • 6.2.4.3.2 Market size and forecast, by End User
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Indication

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Indication
          • 6.3.4.1.2 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Indication
          • 6.3.4.2.2 Market size and forecast, by End User
        • 6.3.4.3 United Kingdom
          • 6.3.4.3.1 Market size and forecast, by Indication
          • 6.3.4.3.2 Market size and forecast, by End User
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Market size and forecast, by Indication
          • 6.3.4.4.2 Market size and forecast, by End User
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Market size and forecast, by Indication
          • 6.3.4.5.2 Market size and forecast, by End User
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Indication
          • 6.3.4.6.2 Market size and forecast, by End User
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Indication

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Market size and forecast, by Indication
          • 6.4.4.1.2 Market size and forecast, by End User
        • 6.4.4.2 China
          • 6.4.4.2.1 Market size and forecast, by Indication
          • 6.4.4.2.2 Market size and forecast, by End User
        • 6.4.4.3 Australia
          • 6.4.4.3.1 Market size and forecast, by Indication
          • 6.4.4.3.2 Market size and forecast, by End User
        • 6.4.4.4 India
          • 6.4.4.4.1 Market size and forecast, by Indication
          • 6.4.4.4.2 Market size and forecast, by End User
        • 6.4.4.5 South Africa
          • 6.4.4.5.1 Market size and forecast, by Indication
          • 6.4.4.5.2 Market size and forecast, by End User
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Market size and forecast, by Indication
          • 6.4.4.6.2 Market size and forecast, by End User
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Indication

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Indication
          • 6.5.4.1.2 Market size and forecast, by End User
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Indication
          • 6.5.4.2.2 Market size and forecast, by End User
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Market size and forecast, by Indication
          • 6.5.4.3.2 Market size and forecast, by End User
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Market size and forecast, by Indication
          • 6.5.4.4.2 Market size and forecast, by End User
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 ABBOTT LABORATORIES

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Boston Scientific Corporation

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 EDWARDS LIFE SCIENCE CORPORATION

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
    TABLE 2. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR CARDIAC ARRRYTHMIAS, BY REGION , 2020-2030,($MILLION)
    TABLE 3. IMPLANTABLE CARDIAC MONITORS MARKET CARDIAC ARRRYTHMIAS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 4. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR ATRIAL FRIBRILLATION, BY REGION , 2020-2030,($MILLION)
    TABLE 5. IMPLANTABLE CARDIAC MONITORS MARKET ATRIAL FRIBRILLATION BY COUNTRY, 2020-2030,($MILLION)
    TABLE 6. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR EPILEPSY AND UNEXPLAINED FALLS, BY REGION , 2020-2030,($MILLION)
    TABLE 7. IMPLANTABLE CARDIAC MONITORS MARKET EPILEPSY AND UNEXPLAINED FALLS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 8. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 9. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
    TABLE 10. IMPLANTABLE CARDIAC MONITORS MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 11. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOME SETTINGS, BY REGION , 2020-2030,($MILLION)
    TABLE 12. IMPLANTABLE CARDIAC MONITORS MARKET HOME SETTINGS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 13. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION , 2020-2030,($MILLION)
    TABLE 14. IMPLANTABLE CARDIAC MONITORS MARKET AMBULATORY SURGICAL CENTERS (ASCS) BY COUNTRY, 2020-2030,($MILLION)
    TABLE 15. IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION, 2020-2030,($MILLION)
    TABLE 16. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
    TABLE 17. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 18. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 19. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 20. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 21. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 22. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 23. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 24. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 25. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
    TABLE 26. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 27. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 28. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 29. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 30. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 31. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 32. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 33. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 34. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 35. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 36. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 37. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 38. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 39. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
    TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 42. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 43. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 44. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 45. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 46. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 47. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 48. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 49. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 50. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 51. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 52. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 53. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 54. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
    TABLE 56. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 57. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 58. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 59. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 60. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 61. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 62. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 63. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 64. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
    TABLE 65. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
    TABLE 66.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 67.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 68.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 69.ABBOTT LABORATORIES: NET SALES,
    TABLE 70.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 71.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 72.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 73.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 74.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 75.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 76.EDWARDS LIFE SCIENCE CORPORATION: COMPANY SNAPSHOT
    TABLE 77.EDWARDS LIFE SCIENCE CORPORATION: OPERATING SEGMENTS
    TABLE 78.EDWARDS LIFE SCIENCE CORPORATION: PRODUCT PORTFOLIO
    TABLE 79.EDWARDS LIFE SCIENCE CORPORATION: NET SALES,
    TABLE 80.EDWARDS LIFE SCIENCE CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.IMPLANTABLE CARDIAC MONITORS MARKET SEGMENTATION
    FIGURE 2.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
    FIGURE 3.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET,BY INDICATION,2020(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CARDIAC ARRRYTHMIAS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ATRIAL FRIBRILLATION IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EPILEPSY AND UNEXPLAINED FALLS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 15.IMPLANTABLE CARDIAC MONITORS MARKET,BY END USER,2020(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOME SETTINGS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS (ASCS) IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
    FIGURE 19.IMPLANTABLE CARDIAC MONITORS MARKET BY REGION,2020
    FIGURE 20.U.S. IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 21.CANADA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 22.MEXICO IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 23.GERMANY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 24.FRANCE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 25.UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 26.ITALY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 27.SPAIN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 28.REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 29.JAPAN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 30.CHINA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 31.AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 32.INDIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 33.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 34.REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 35.BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 36.SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 37.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 38.REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
    FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 43.COMPETITIVE DASHBOARD
    FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 45.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 46.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 47.EDWARDS LIFE SCIENCE CORPORATION.: NET SALES ,($MILLION)

 
 

The utilization of implantable cardiac monitor (ICM) devices is expected to increase, due to the increase in incidence of cardiovascular disorders. Significant technological advancements in ICMs is observed to provide advanced treatment options for patients suffering from chronic diseases. North America is projected to be  highest revenue contributor, whereas Asia-Pacific is expected to offer lucrative opportunities to key players in this market.

Rise in incidence of cardiac disorders, increase in changes in lifestyle, technological advancements, and surge in patient awareness regarding cardiac ailments and benefits of ICMs in the developing regions drive the market growth. However, high cost of devices and unstable reimbursement policies impede the market growth. Moreover, high unmet medical needs in developing countries, including China, India, and Brazil are expected to provide lucrative growth opportunities for key players.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of implantable cardiac monitors market is $974.42 million in 2030.

A. Top companies such as General Electric Company, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Edward Lifesciences Corporation, Nihon Kohden Corporation held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Cardiac Arrrythmias segment is the most influencing segment owing to the implantable nature of this monitor which does not require patient to be admitted to hospital, and patient can be monitored while performing his or her daily activities.

A. The forecast period for implantable cardiac monitors market is 2020 to 2030

A. The market value of implantable cardiac monitors market in 2020 is $500.02 million.

A. The increase in incidence of patients suffering from atrial fibrillation, rise in prevalence of myocardial infraction, and surge in unhealthy lifestyle are the key trends in the implantable cardiac monitors market report.

A. The base year is 2020 in implantable cardiac monitors market

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Implantable Cardiac Monitors Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers